clinics offering personalized weight loss plans with compounded semaglutide Cut the cost, not the results 💚 Take advantage of our ½ OFF office visits when prescribed medications like tirzepatide & semaglutide. Your journey to a healthier you just Weight Loss

Medicare Is About to Cover Weight-Loss Drugs for the First Time Here's What the GLP-1 Bridge Program Means for Millions of Americans with Obesity Three weeks from now, on July 1, 2026, millions of older Americans with obesity will gain access to GLP-1 weight-loss medications through Medicare for the first time in the program's 60-year history

The dual burden of obesity and type 2 diabetes is rapidly emerging as a major public health challenge in India

Consequences of inflammation on taste buds Extra-oral expression of taste receptors are implicated in innate immunity, inflammatory and autoimmune diseases are associated with altered taste perception, highlighting the potential relevance of taste cell-immune system-crosstalk [142165]

As people using GLP-1 and GLP-1/GIP RA therapy lose weight and no longer meet plan-defined criteria, coverage can be withdrawn, forcing nonmedically indicated discontinuation and destabilizing care (e.g., rapid weight regains and worsening glycemia)

Rights and permissions About this article Cite this article Halpin, L., Northrop, N